RIM
ALXN

Rampart Investment Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Rampart Investment Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-1,370
Closed -$157K – 394
2020
Q3 		$157K Sell
1,370
-3,121
-69% -$337K 0.1% 204
2020
Q2 		$504K Buy
4,491
+1,234
+38% +$131K 0.08% 255
2020
Q1 		$292K Buy
3,257
+634
+24% +$62.2K 0.14% 151
2019
Q4 		$284K Buy
2,623
+91
+4% +$9.73K 0.03% 401
2019
Q3 		$248K Sell
2,532
-64
-2% -$7.21K 0.03% 401
2019
Q2 		$340K Sell
2,596
-128
-5% -$16.5K 0.04% 364
2019
Q1 		$368K Buy
2,724
+334
+14% +$41.5K 0.04% 363
2018
Q4 		$233K Sell
2,390
-1,986
-45% -$235K 0.06% 239
2018
Q3 		$608 Sell
4,376
-4,226
-49% -$530K ﹤0.01% 498
2018
Q2 		$1.07M Buy
8,602
+5,033
+141% +$588K 0.1% 258
2018
Q1 		$398K Buy
+3,569
New +$427K 0.04% 366
2017
Q4 		– Sell
-3,076
Closed -$432K – 519
2017
Q3 		$432K Buy
3,076
+112
+4% +$15.2K 0.15% 163
2017
Q2 		$361K Buy
2,964
+2,340
+375% +$272K 0.13% 182
2017
Q1 		$76K Sell
624
-3,843
-86% -$495K 0.03% 186
2016
Q4 		$546K Sell
4,467
-14
-0.3% -$1.71K 0.2% 93
2016
Q3 		$550K Buy
+4,481
New +$577K 0.21% 100

Other funds holding ALXN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Rampart Investment Management's ALXN Position: Q4 2020 in Review

Rampart Investment Management sold out of Alexion Pharmaceuticals (ALXN) in Q4 2020, closing a stake of 1,370 shares — an estimated $157K sold.

Rampart Investment Management first reported a position in ALXN in Q3 2016 and held it in 16 quarters. The position peaked at $1.07M in Q2 2018. 825 funds tracked by Wall St. Rank hold ALXN as of Q4 2020.

  • Rampart Investment Management reported no remaining Alexion Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Rampart Investment Management sold 1,370 Alexion Pharmaceuticals shares in Q4 2020, an estimated $157K.
  • Rampart Investment Management first reported a position in Alexion Pharmaceuticals in Q3 2016 and held it in 16 quarters.
  • Rampart Investment Management's Alexion Pharmaceuticals position peaked at $1.07M in Q2 2018.
  • 825 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q4 2020.

Based on Rampart Investment Management's 13F filing for Q4 2020.